|
業務類別
|
Biotechnology |
|
業務概覽
|
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. Currently it has two marketed drugs that target C3, the central protein in the complement cascade: SYFOVRE (pegcetacoplan injection) and EMPAVELI (pegcetacoplan). |
| 公司地址
| 100 Fifth Avenue, Waltham, MA, USA, 02451 |
| 電話號碼
| +1 617 977-5700 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.apellis.com |
| 員工數量
| 739 |
| Mr. David Acheson |
Executive Vice President, Commercial |
-- |
13/01/2025 |
| Mr. Timothy E. Sullivan |
Chief Financial Officer and Treasurer |
美元 530.96K |
24/02/2026 |
| Dr. Cedric Francois, M.D. |
Director, Chief Executive Officer and President |
美元 793.19K |
24/02/2026 |
| Mr. Pascal Deschatelets, PhD |
Chief Scientific Officer |
-- |
23/04/2025 |
| Mr. David Watson |
General Counsel and Secretary |
美元 513.08K |
23/04/2025 |
| Ms. Nur Nicholson |
Chief Technical Operations Officer |
-- |
23/04/2025 |
| Mr. James George Chopas |
Vice President, Corporate Controller, Treasurer and Chief Accounting Officer |
-- |
24/02/2026 |
| Dr. Caroline Baumal, M.D. |
Chief Medical Officer |
美元 610.39K |
23/04/2025 |
| Mr. Mark Jeffrey DeLong |
Chief Business and Strategy Officer |
-- |
23/04/2025 |
|
|
| Ms. Keli Walbert |
Independent Director |
24/02/2026 |
| Mr. Alec Machiels |
Independent Director |
24/02/2026 |
| Dr. Gerald L. Chan, Sc.D. |
Chairman of the Board |
24/02/2026 |
| Ms. Stephanie Monaghan O’Brien |
Independent Director |
24/02/2026 |
| Dr. Cedric Francois, M.D. |
Director, Chief Executive Officer and President |
24/02/2026 |
| Mr. A. Sinclair Dunlop |
Independent Director |
24/02/2026 |
| Mr. Paul Fonteyne, M.S. |
Independent Director |
24/02/2026 |
| Dr. G. Mikael Dolsten, M.D.,PhD |
Independent Director |
02/03/2026 |
| Mr. Craig A. Wheeler |
Independent Director |
24/02/2026 |
|
|
|
|
